ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
BKA Dayyeh, N Kumar, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
Bariatric and metabolic surgery: a shift in eligibility and success criteria
G Frühbeck - Nature Reviews Endocrinology, 2015 - nature.com
The obesity epidemic, combined with the lack of available and effective treatments for
morbid obesity, is a scientific and public health priority. Worldwide, bariatric and metabolic …
morbid obesity, is a scientific and public health priority. Worldwide, bariatric and metabolic …
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
Bariatric surgery is the most effective treatment for obesity and also greatly improves
glycaemic control, often within days after surgery, independently of weight loss …
glycaemic control, often within days after surgery, independently of weight loss …
Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss …
P Jirapinyo, AV Haas, CC Thompson - Diabetes care, 2018 - Am Diabetes Assoc
OBJECTIVE Duodenal-jejunal bypass liner (DJBL) is an endoscopic device that may mimic
small bowel mechanisms of Roux-en-Y gastric bypass (RYGB). Previous studies have …
small bowel mechanisms of Roux-en-Y gastric bypass (RYGB). Previous studies have …
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies
ABET Force, BKA Dayyeh, N Kumar… - Gastrointestinal …, 2015 - pubmed.ncbi.nlm.nih.gov
The increasing global burden of obesity and its associated comorbidities has created an
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
urgent need for additional treatment options to fight this pandemic. Endoscopic bariatric …
The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial
P Koehestanie, C de Jonge, FJ Berends, IM Janssen… - 2014 - journals.lww.com
Objective: Investigate the safety and efficacy of 6 months' duodenal-jejunal bypass liner
(DJBL) treatment in comparison with dietary intervention for obesity and type 2 diabetes …
(DJBL) treatment in comparison with dietary intervention for obesity and type 2 diabetes …
Endoscopic bariatric therapies
BKA Dayyeh, SA Edmundowicz… - Gastrointestinal …, 2015 - giejournal.org
BACKGROUND More than one-third of US adults are obese. 1 The increasing prevalence of
obesity in the United States has been accompanied by an increasing prevalence in its …
obesity in the United States has been accompanied by an increasing prevalence in its …
Recent advances in clinical practice challenges and opportunities in the management of obesity
Despite advances in understanding the roles of adiposity, food intake, GI and adipocyte-
related hormones, inflammatory mediators, the gut–brain axis and the hypothalamic nervous …
related hormones, inflammatory mediators, the gut–brain axis and the hypothalamic nervous …
Therapeutic luminal coating of the intestine
Y Lee, TE Deelman, K Chen, DSY Lin, A Tavakkoli… - Nature Materials, 2018 - nature.com
The gastrointestinal tract is the site of most drug delivery and therapeutic interventions for
the management and treatment of numerous diseases. However, selective access to its …
the management and treatment of numerous diseases. However, selective access to its …
Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism
N Vilarrasa, AGR de Gordejuela, A Casajoana… - Obesity surgery, 2017 - Springer
Background The purpose of this study was to evaluate the efficacy and safety of
Endobarrier® in grade 1 obese T2DM patients with poor metabolic control and the role of …
Endobarrier® in grade 1 obese T2DM patients with poor metabolic control and the role of …